Darrell Borger is an accomplished professional in the field of oncology and translational science. Recent positions include Director of Translational Science and Head of Experimental & Molecular Pathology at Takeda Oncology, along with previous roles as Associate Director of Translational Science and Head of the Integrated Translational Technology Laboratory in the Oncology Drug Development Unit. Prior experience includes serving as Scientific Director for the Immuno-Oncology Laboratory at Massachusetts General Hospital and leadership roles in the Translational Research Laboratory. Additionally, Darrell held a position as Instructor in Medicine at Harvard Medical School and completed a Research Fellowship at Dana-Farber Cancer Institute. Darrell Borger earned a PhD in Biomedical Science from the University of South Carolina School of Medicine.